OmpW is a potential target for eliciting protective immunity against Acinetobacter baumannii infections

Vaccine

Volumn 33, Issue 36, 2015, Pages 4479-4485

  Huang, Weiwei ^a   Wang, Shijie ^a   Yao, Yufeng ^a   Xia, Ye ^a   Yang, Xu ^a   Long, Qiong ^a   Sun, Wenjia ^a   Liu, Cunbao ^a   Li, Yang ^a   Ma, Yanbing ^a  

^a INSTITUTE OF MEDICAL BIOLOGY   (China)

Author keywords

Acinetobacter baumannii; Outer membrane protein W; Protective immunity; Vaccine

Indexed keywords

AMINO ACID; ANTIBODY; CHEMOKINE; COMPLEMENT; GAMMA INTERFERON; HYBRID PROTEIN; IMMUNOGLOBULIN G; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; OUTER MEMBRANE PROTEIN W; THIOREDOXIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; BACTERIAL VACCINE; BACTERIUM ANTIBODY; CYTOKINE; OPSONIN; OUTER MEMBRANE PROTEIN; RECOMBINANT VACCINE;

ACINETOBACTER INFECTION; ACTIVE IMMUNIZATION; AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASSAY; BACTERIAL LOAD; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IN VITRO STUDY; IN VIVO STUDY; INFECTION CONTROL; INFECTION PREVENTION; MACROPHAGE; MOUSE; NONHUMAN; OPSONOPHAGOCYTIC ASSAY; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; SEPSIS; SURVIVAL; SURVIVAL RATE; ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANIMAL; ANIMAL STRUCTURES; BLOOD; DISEASE MODEL; GENETICS; IMMUNOLOGY; INSTITUTE FOR CANCER RESEARCH MOUSE; MICROBIOLOGY; RAW 264.7 CELL LINE; SURVIVAL ANALYSIS;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANIMAL STRUCTURES; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL LOAD; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; COMPLEMENT SYSTEM PROTEINS; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN G; MACROPHAGES; MICE; MICE, INBRED ICR; OPSONIN PROTEINS; RAW 264.7 CELLS; SEPSIS; SURVIVAL ANALYSIS; VACCINES, SYNTHETIC;

EID: 84939571378     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.07.031     Document Type: Article

References (32)

1. Davis K.A., Moran K.A., McAllister C.K., Gray P.J. Multidrug-resistant Acinetobacter extremity infections in soldiers. Emerg Infect Dis 2005, 11:1218-1224.
2. Jones A., Morgan D., Walsh A., Turton J., Livermore D., Pitt T., et al. Importation of multidrug-resistant Acinetobacter spp infections with casualties from Iraq. Lancet Infect Dis 2006, 6:317-318.
3. Petersen K., Riddle M.S., Danko J.R., Blazes D.L., Hayden R., Tasker S.A., et al. Trauma-related infections in battlefield casualties from Iraq. Ann Surg 2007, 245:803-811.
4. Garcia-Quintanilla M., Pulido M.R., Lopez-Rojas R., Pachon J., McConnell M.J. Emerging therapies for multidrug resistant Acinetobacter baumannii. Trends Microbiol 2013, 21:157-163.
5. Wang H., He Y., Xia Y., Wang L., Liang S. Inhibition of gene expression and growth of multidrug-resistant Acinetobacter baumannii by antisense peptide nucleic acids. Mol Biol Rep 2014, 41:7535-7541.
6. Lin B., Merabishvili M., Vandenheuvel D., Kropinski A.M., Mast J., De Vos D., et al. Characterization of newly isolated lytic bacteriophages active against Acinetobacter baumannii. PLOS ONE 2014, 9:e104853.
7. de Leeuw E.P. Efficacy of the small molecule inhibitor of Lipid II BAS00127538 against Acinetobacter baumannii. Drug Des Dev Ther 2014, 8:1061-1064.
8. Lin L., Tan B., Pantapalangkoor P., Ho T., Baquir B., Tomaras A., et al. Inhibition of LpxC protects mice from resistant Acinetobacter baumannii by modulating inflammation and enhancing phagocytosis. mBio 2012, 3. e00312-12-e-12.
9. Vila-Farres X., Garcia de la Maria C., Lopez-Rojas R., Pachon J., Giralt E., Vila J. In vitro activity of several antimicrobial peptides against colistinsusceptible and colistin-resistant Acinetobacter baumannii. Clin Microbiol Infect 2012, 18:383-387.
10. Saugar J.M., Rodriguez-Hernandez M.J., de la Torre B.G., Pachon-Ibanez M.E., Fernandez-Reyes M., Andreu D., et al. Activity of Cecropin A-Melittin hybrid peptides against Colistin-resistant clinical strains of Acinetobacter baumannii: molecular basis for the differential mechanisms of action. Antimicrob Agents Chemother 2006, 50:1251-1256.
11. Saugar J.M., Alarcon T., Lopez-Hernandez S., Lopez-Brea M., Andreu D., Rivas L. Activities of Polymyxin B and Cecropin A-Melittin Peptide CA(1-8)M(1-18) against a multiresistant strain of Acinetobacter baumannii. Antimicrob Agents Chemother 2002, 46:875-878.
12. Goel V.K., Kapil A. Monoclonal antibodies against the iron regulated outer membrane proteins of Acinetobacter baumannii are bactericidal. BMC Microbiol 2001, 1:16.
13. McConnell M.J., Pachón J. Active and passive immunization against Acinetobacter baumannii using an inactivated whole cell vaccine. Vaccine 2010, 29:1-5.
14. Harris G., Kuo Lee R., Lam C.K., Kanzaki G., Patel G.B., Xu H.H., et al. A mouse model of Acinetobacter baumannii-associated pneumonia using a clinically isolated hypervirulent strain. Antimicrob Agents Chemother 2013, 57:3601-3613.
15. McConnell M.J., Dominguez-Herrera J., Smani Y., Lopez-Rojas R., Docobo-Perez F., Pachon J. Vaccination with outer membrane complexes elicits rapid protective immunity to multidrug-resistant Acinetobacter baumannii. Infect Immun 2010, 79:518-526.
16. McConnell M.J., Rumbo C., Bou G., Pachón J. Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii. Vaccine 2011, 29:5705-5710.
17. Huang W., Yao Y., Long Q., Yang X., Sun W., Liu C., et al. Immunization against multidrug-resistant Acinetobacter baumannii effectively protects mice in both pneumonia and sepsis models. PLOS ONE 2014, 9:e100727.
18. Fattahian Y., Rasooli I., Mousavi Gargari S.L., Rahbar M.R., Darvish Alipour Astaneh S., Amani J. Protection against Acinetobacter baumannii infection via its functional deprivation of biofilm associated protein (Bap). Microb Pathog 2011, 51:402-406.
19. Bentancor L.V., O'Malley J.M., Bozkurt-Guzel C., Pier G.B., Maira-Litran T. Poly-N-Acetyl-(1-6)-Glucosamine is a target for protective immunity against Acinetobacter baumannii infections. Infect Immun 2011, 80:651-656.
20. Bentancor L.V., Routray A., Bozkurt-Guzel C., Camacho-Peiro A., Pier G.B., Maira-Litran T. Evaluation of the trimeric autotransporter ata as a vaccine candidate against Acinetobacter baumannii infections. Infect Immun 2012, 80:3381-3388.
21. Russo T.A., Beanan J.M., Olson R., MacDonald U., Cox A.D., St Michael F., et al. The K1 capsular polysaccharide from Acinetobacter baumannii is a potential therapeutic target via passive immunization. Infect Immun 2013, 81:915-922.
22. Luo G., Lin L., Ibrahim A.S., Baquir B., Pantapalangkoor P., Bonomo R.A., et al. Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection. PLoS ONE 2012, 7:e29446.
23. Santos P., Tiwari V., Vashistt J., Kapil A., Moganty R.R. Comparative proteomics of inner membrane fraction from carbapenem-resistant Acinetobacter baumannii with a reference strain. PLoS ONE 2012, 7:e39451.
24. McConnell M.J., Hanna P.C., Imperiale M.J. Cytokine response and survival of mice immunized with an adenovirus expressing Bacillus anthracis protective antigen domain 4. Infect Immun 2006, 74:1009-1015.
25. Garcia-Quintanilla M., Pulido M.R., Pachon J., McConnell M.J. Immunization with lipopolysaccharide-deficient whole cells provides protective immunity in an experimental mouse model of Acinetobacter baumannii infection. PLOS ONE 2014, 9:e114410.
26. Collins B.S. Gram-negative outer membrane vesicles in vaccine development. Discov Med 2011, 12:7-15.
27. LaVallie E.R., DiBlasio E.A., Kovacic S., Grant K.L., Schendel P.F., McCoy J.M. A thioredoxin gene fusion expression system that circumvents inclusion body formation in the E. coli cytoplasm. Biotechnology (NY) 1993, 11:187-193.
28. McConnell M.J., Pachón J. Expression, purification, and refolding of biologically active Acinetobacter baumannii OmpA from Escherichia coli inclusion bodies. Protein Expr Purif 2011, 77:98-103.
29. Choi C.H., Lee E.Y., Lee Y.C., Park T.I., Kim H.J., Hyun S.H., et al. Outer membrane protein 38 of Acinetobacter baumannii localizes to the mitochondria and induces apoptosis of epithelial cells. Cell Microbiol 2005, 7:1127-1138.
30. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
31. Hanahan D., Weinberg Robert A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
32. KuoLee R., Harris G., Yan H., Xu H.H., Conlan W.J., Patel G.B., et al. Intranasal immunization protects against Acinetobacter baumannii-associated pneumonia in mice. Vaccine 2015, 33:260-267.